Industry opposition stalls bid to ban branded generics in India

Efforts on the part of the Indian government to scrap branded generics have stalled, with a draft policy making no progress since it was circulated last year.

Indian press reports that opposition from industry and certain government agencies has prevented momentum from gaining behind the measures.

The price-curbing  initiative from the Department of Pharmaceuticals was always likely to prove controversial in a country which derives the lion’s share of its pharmaceuticals profits from this type of product.